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The molecular processes underlying intestinal adaptation to fasting and re-feeding remain largely
uncharacterized. In this issue of Cell Reports, Richmond et al. report that dormant intestinal
stem cells are regulated by PTEN and nutritional status.Fasting has been practiced since ancient
times by different ethnic or religious
groups throughout the world. It is known
that fasting can be a powerful trigger
that causes robust metabolic responses,
including reduced insulin secretion
and glycogenesis, thus promoting sur-
vival. Fasting is also known to promote
longevity, in part by reducing risks of can-
cer, diabetes, heart diseases, and neuro-
degeneration (Longo and Mattson,
2014). However, the underlying mecha-
nisms regarding whether and how fasting
affects tissue homeostasis and regenera-
tion remain largely unclear.
Previously, Yilmaz et al. (2012) reported
that calorie restriction promotes self-
renewal of intestinal stem cells (ISCs)
indirectly through the inhibition of the
mammalian target of rapamycin complex
1 (mTORC1) pathway in Paneth cells.
Paneth cells in turn act as a regulatory
niche to augment stem-cell function in
response to calorie restriction by reducing
mTORC1 signaling. However, how adult
stem cells directly respond to the change
in nutritional states remains unresolved. In
this issue of Cell Reports, Richmond et al.
(2015) reveal the differential responses of
rapidly cycling ISCs (r-ISCs) and dormant
ISCs (d-ISCs) to fasting.
The role of Paneth cells in supporting
ISCs in response to calorie restriction
was previously shown in a study where
Paneth cells isolated from calorie-
restricted mice were found to promote
expansion of Lgr5+ ISCs in organoid cul-
ture more effectively than cells from
well-fed mice (Yilmaz et al., 2012). Rich-
mond et al. (2015) directly assessed
changes to Lgr5+ r-ISCs in response to
fasting and revealed reduced Lgr5+ cell
numbers and declined Lgr5-induced line-ages (Figure 1). The authors also investi-
gated the role of the mTOR pathway,
which is normally not active in d-ISCs
due to the suppression by its upstream
factor PTEN. PTEN and its inactive iso-
form, phosphor (p)-PTEN, are known to
be present in quiescent +4 ISCs, and
function respectively to control quiescent
and active states of +4 ISCs by regulating
the PI3K-Akt pathway (He et al., 2004,
2007). Given that PTEN can also func-
tion as a gatekeeper of the fasting-fed
transition (Pal et al., 2012), the authors
reasoned that PTEN may regulate
d-ISCs. Indeed, they found that fasting
led to PTEN inhibition, as revealed by con-
version into the p-PTEN state and activa-
tion of mTOR in d-ISCs, rendering d-ISCs
into a functionally poised or primed state
(Figure 1). Upon subsequent re-feeding,
these primed d-ISCs increased in number
and robustly contributed to lineage regen-
eration, as evidenced by an increased
mTert-induced lineage tracing. After-
ward, however, the d-ISCs initiated pro-
grammed cell death to get rid of excessive
ISCs produced during the fasting-re-
feeding process and eventually returned
to their dormant state and original num-
ber (Figure 1). Richmond et al. (2015)
confirmed the function of PTEN as a
negative regulator of the PI3K/AKT
signaling pathway in d-ISCs and further
showed its role in maintaining d-ISCs
via inhibition of the mTORC1 activity.
This conclusion is further supported by
the fact that lacking PTEN attenuated
post-injury regenerative capacity, which
depends primarily on d-ISCs, but not
r-ISCs, because the latter are sensitive
to irradiation. Richmond et al. (2015)
thus shed new light on the PTEN-depen-
dent mechanism for d-ISC maintenanceCell Reports 13, Deand further demonstrate the role of
d-ISCs functioning as reserve ISCs in
response to fasting.
This original finding regarding the fast-
ing response by r-ISCs and d-ISCs is
largely consistent with previously pro-
posed functions of active and quiescent
stem cells coexisting in the intestinal
crypt (Li and Clevers, 2010). Reserve
ISCs are defined by function and d-ISCs
by state. The sensitivity of active ISCs
and resistance of quiescent ISCs to
chemo- and/or radio-therapy have been
well documented (Asfaha et al., 2015;
Takeda et al., 2011). However, the differ-
ential response to fasting by r-ISCs and
d-ISCs is a novel observation (Figure 1).
The primed or poised state described in
this report is different from the active-
cycling state, reflecting more appropri-
ately a transitional state from dormancy
into cycling.
Fasting may have an unrecognized
role in cancer prevention and treatment.
Recent studies suggest that the combina-
tion of fasting with chemotherapy is highly
effective in treatment of cancer (Longo
and Mattson, 2014). This can be ex-
plained in two aspects. Fastingmay prime
chemo-resistant cancer cells to increase
sensitivity to treatment. Short-term fast-
ing before and immediately after chemo-
therapy may minimize side effects, such
as nausea and other adverse gastroin-
testinal reactions (Scrable, 2012). The
work by Richmond et al. (2015) indicates
that fasting-refeeding leads to more rapid
restoration of the integrity and function of
the intestine, thus suggesting that fasting-
refeeding might reduce chemotherapy-
associated side effects.
Here, we would like to point out that





















Figure 1. Differential Responses of Stem Cells to Fasting
Differential responses of r-ISCs and d-ISCs to fasting. Whereas r-ISCs (Lgr5+) reduced in number and
declined in Lgr5:Cre-induced lineages in response to fasting, d-ISCs (PTEN+ or mTert+) became primed
and increased in mTert:Cre-induced lineages upon refeeding.between caloric restriction and fasting,
with the former reducing daily caloric
intake by 20%–40%, but maintaining
meal frequency (Longo and Mattson,
2014), whereas the latter withdraws
nutrients completely. Fasting may pro-
vide effective strategies to delay aging,2326 Cell Reports 13, December 22, 2015 ª2reduce weight, and optimize health.
The potent effects of different terms of
fasting, including alternate day fasting
or fasting for 2 days a week, should
be studied, given that circadian rhythms
are of high importance to metabolism
control.015 The AuthorsThe PI3K/AKT/mTORC1 signaling
pathway as highlighted in this study is
essential for growth and survival (Rich-
mond et al., 2015), the downstream of
which still needs a better understanding
such as cellular metabolism and regener-
ation. mTOR signaling is a critical target
for therapeutic approaches and has
driven the development of a number of
mTOR inhibitors including rapamycin.
Synergistic strategies with other means
should be considered in an effort to
enhance therapeutic efficacy, given that
mTOR inhibitors remain a promising ther-
apeutic option for cancer treatment.REFERENCES
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